Aikili Biosystems Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Aikili Biosystems General Information
Description
Operator of a single-cell analysis platform intended to develop new protein biomarkers for precision oncology. The company specializes in providing multiplexed protein analysis, with initial applications in solid tumor profiling and biomarker validation and profiling in trials for immunotherapies, enabling researchers to provide access to effective diagnosis and improve health.
Contact Information
Website
www.aikilibio.comCorporate Office
- 34 Cambridge Terrace Apartment 3
- Cambridge, MA 02140
- United States
Corporate Office
- 34 Cambridge Terrace Apartment 3
- Cambridge, MA 02140
- United States
Aikili Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 29-Sep-2026 | Completed | Out of Business | |||
| 2. Early Stage VC | 01-Jan-2020 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Aikili Biosystems FAQs
-
When was Aikili Biosystems founded?
Aikili Biosystems was founded in 2019.
-
Where is Aikili Biosystems headquartered?
Aikili Biosystems is headquartered in Cambridge, MA.
-
What industry is Aikili Biosystems in?
Aikili Biosystems’s primary industry is Decision/Risk Analysis.
-
Is Aikili Biosystems a private or public company?
Aikili Biosystems is a Private company.
-
What is Aikili Biosystems’s current revenue?
The current revenue for Aikili Biosystems is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process